Regulation of the reproductive cycle and early pregnancy by relaxin family peptides

Molecular and Cellular Endocrinology

Volumn 382, Issue 1, 2014, Pages 472-479

  Anand Ivell, Ravinder ^a   Ivell, Richard ^a  

^a LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

Author keywords

Implantation; INSL3; Ovarian follicle growth; Relaxin

Indexed keywords

ANDROGEN; HORMONE RECEPTOR; INSULIN; INSULIN LIKE PEPTIDE 3; INSULIN LIKE PEPTIDE 4; INSULIN LIKE PEPTIDE 5; INSULIN LIKE PEPTIDE 6; RELAXIN; RXFP1 PROTEIN; RXFP2 PROTEIN; UNCLASSIFIED DRUG;

AMNION FLUID; CARDIOVASCULAR SYSTEM; CELL GROWTH; CORPUS LUTEUM; DISEASE ASSOCIATION; EMBRYO; ENDOMETRIUM; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HORMONE SYNTHESIS; HUMAN; IMMUNE SYSTEM; INTRAUTERINE GROWTH RETARDATION; MALE; NIDATION; NONHUMAN; OVARY CYCLE; OVARY FOLLICLE; OVARY FUNCTION; OVULATION; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REPRODUCTION; REVIEW; SEX DETERMINATION; TESTIS DESCENT; VASCULARIZATION;

IMPLANTATION; INSL3; OVARIAN FOLLICLE GROWTH; RELAXIN;

ANIMALS; FEMALE; HUMANS; INSULIN; PREGNANCY; PROTEINS; RELAXIN; REPRODUCTION;

EID: 84888294429     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.08.010     Document Type: Review

References (102)

1. Adham I.M., Burkhardt E., Benahmed M., Engel W. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J. Biol. Chem. 1993, 268:26668-26672.
2. Amory J.K., Page S.T., Anawalt B.D., Coviello A.D., Matsumoto A.M., Bremner W.J. Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception. J. Androl. 2007, 28:548-554.
3. Anand-Ivell R., Heng K., Bartsch O., Ivell R. Relaxin signalling in THP-1 cells uses a novel phosphotyrosine-dependent pathway. Mol. Cell. Endocrinol. 2007, 272:1-13.
4. Anand-Ivell R., Ivell R., Driscoll D.A., Manson J. INSL3 Levels in amniotic fluid from human male fetuses. Hum. Reprod. 2008, 23:1180-1186.
5. Anand-Ivell R., Hiendleder S., Viñoles C., Martin G.B., Fitzsimmons C., Eurich A., Hafen B., Ivell R. INSL3 in the ruminant: a powerful indicator of gender- and genetic-specific feto-maternal dialogue. PLoS ONE 2011, 6:e19821.
6. Anand-Ivell R., Dai Y., Ivell R. Neohormones as biomarkers of reproductive health. Fertil. Steril. 2013, 99:1153-1160.
7. Anand-Ivell, R., Tremellen, K., Dai, Y., Heng, K., Yoshida, M., Knight, P.G., Hale, G.E., Ivell, R., 2013. Circulating Insulin-like factor 3 (INSL3) in healthy and infertile women. Hum. Reprod. (accepted for publication).
8. Anumba D.O., El Gelany S., Elliott S.L., Li T.C. Serum relaxin levels are reduced in pregnant women with a history of recurrent miscarriage, and correlate with maternal uterine artery Doppler indices in first trimester. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 147:41-45.
9. Arroyo J.I., Hoffmann F.G., Good S., Opazo J.C. INSL4 pseudogenes help define the relaxin family repertoire in the common ancestor of placental mammals. J. Mol. Evol. 2012, 75:73-78.
10. Balvers M., Spiess A.N., Domagalski R., Hunt N., Kilic E., Mukhopadhyay A.K., Hanks E., Charlton H.M., Ivell R. Relaxin like factor (RLF) expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 1998, 139:2960-2970.
11. Bamberger A.M., Ivell R., Balvers M., Kelp B., Riethdorf L., Löning T. Relaxin like factor (RLF), a novel member of the insulin IGF relaxin family, is a new specific marker for hilus/Leydig cells in the human ovary. Int. J. Gynecol. Pathol. 1999, 18:163-168.
12. Bartsch O., Bartlick B., Ivell R. Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol. Hum. Reprod. 2001, 7:799-809.
13. Bartsch O., Bartlick B., Ivell R. Phosphodiesterase 4 inhibition synergizes with relaxin signalling to promote decidualization of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 2004, 89:324-334.
14. Bathgate R., Balvers M., Hunt N., Ivell R. The relaxin like factor (RLF) is upregulated in the bovine ovary of the cycle and pregnancy: sequence and mRNA analysis. Biol. Reprod. 1996, 55:1452-1457.
15. Bathgate R., Moniac N., Bartlick B., Schumacher M., Fields M., Ivell R. Expression and regulation of relaxin like factor (RLF) gene transcripts in the bovine ovary: differentiation dependent expression in theca cell cultures. Biol. Reprod. 1999, 61:1090-1098.
16. Bathgate R.A., Hsueh A.J., Ivell R., Sanborn B.M., Sherwood O.D., Summers R.J. International Union of Pharmacology. Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol. Rev. 2006, 58:7-31.
17. Bell S.C., Jackson J.A., Ashmore J., Zhu H.H., Tseng L. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J. Clin. Endocrinol. Metab. 1991, 72:1014-1024.
18. Blankenship T., Stewart D.R., Benirschke K., King B., Lasley B.L. Immunocytochemical localization of nonluteal ovarian relaxin. J. Reprod. Med. 1994, 39:235-240.
19. Bogatcheva N.V., Truong A., Feng S., Engel W., Adham I.M., Agoulnik A.I. GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol. Endocrinol. 2003, 17:2639-2646.
20. Brännström M., MacLennan A.H. Relaxin induces ovulations in the in vitro perfused rat ovary. Hum. Reprod. 1993, 8:1011-1014.
21. Braun B.C., Vargas A., Jewgenow K. The molecular detection of relaxin and its receptor RXFP1 in reproductive tissue of Felis catus and Lynx pardinus during pregnancy. Reproduction 2012, 143:399-410.
22. Büllesbach E.E., Rhodes R., Rembiesa B., Schwabe C. The relaxin-like factor is a hormone. Endocrine 1999, 10:167-169.
23. Burnicka-Turek O., Shirneshan K., Paprotta I., Grzmil P., Meinhardt A., Engel W., Adham I.M. Inactivation of insulin-like factor 6 disrupts the progression of spermatogenesis at late meiotic prophase. Endocrinology 2009, 150:4348-4357.
24. Burnicka-Turek O., Mohamed B.A., Shineshan K., Thanasupawat T., Hombach-Klonisch S., Klonisch T., Adham I.M. INSL5-deficient mice display an alteration in glucose homeostasis and an impaired fertility. Endocrinology 2012, 153:4655-4665.
25. Conrad K.P. Maternal vasodilation in pregnancy: the emerging role of relaxin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R267-R275.
26. Einspanier A., Müller D., Lubberstedt J., Bartsch O., Jurzinski A., Fuhrmann K., Ivell R. Characterization of relaxin binding in the uterus of the marmoset monkey. Mol. Hum. Reprod. 2001, 7:963-970.
27. Einspanier A., Lieder K., Husen B., Ebert K., Lier S., Einspanier R., Unemori E., Kemper M. Relaxin supports implantation and early pregnancy in the marmoset monkey. Ann. N. Y. Acad. Sci. 2009, 1160:140-146.
28. Ferlin A., Pepe A., Gianesello L., Garolla A., Feng S., Giannini S., Zaccolo M., Facciolli A., Morello R., Agoulnik A.I., Foresta C. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J. Bone Miner. Res. 2008, 23:683-693.
29. Ferlin A., Menegazzo M., Gianesello L., Selice R., Foresta C. Effect of relaxin on human sperm functions. J. Androl. 2012, 33:474-482.
30. Feugang J.M., Greene J.M., Willard S.T., Ryan P.L. In vitro effects of relaxin on gene expression in porcine cumulus-oocyte complexes and developing embryos. Reprod. Biol. Endocrinol. 2011, 9:15.
31. Feugang J.M., Rodriguez-Munoz J.C., Willard S.T., Bathgate R.A., Ryan P.L. Examination of relaxin and its receptors expression in pig gametes and embryos. Reprod. Biol. Endocrinol. 2011, 9:10.
32. Gambineri A., Patton L., De Iasio R., Palladoro F., Pagotto U., Pasquali R. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2007, 92:2066-2073.
33. Gellersen B., Brosens I.A., Brosens J.J. Decidualization of the human endometrium: mechanism, functions, and clinical perspectives. Semin. Reprod. Med. 2007, 25:445-453.
34. Ghattas M.H., Mehanna E.T., Mesbah N.M., Abo-Elmatty D.M. Relaxin-3 is associated with metabolic syndrome and its component traits in women. Clin. Biochem. 2013, 46:45-48.
35. Glister C., Satchell L., Bathgate R.A., Wade J.D., Dai Y., Ivell R., Anand-Ivell R., Rodgers R.J., Knight P.G. A functional link between Bone Morphogenetic Protein and Insulin-like Peptide 3 signaling in modulating ovarian androgen production. Proc. Natl. Acad. Sci. USA 2013, 110:E1426-E1435.
36. Goldsmith L.T., Weiss G., Palejwala S., Plant T.M., Wojtczuk A., Lambert W.C., Ammur N., Heller D., Skurnik J.H., Edwards D., Cole D.M. Relaxin regulation of endometrial structure and function in the rhesus monkey. Proc. Natl. Acad. Sci. USA 2004, 101:4685-4689.
37. Granot I., Gnainsky Y., Dekel N. Endocmetrial inflammation and effect on implantation improvement and pregnancy outcome. Reproduction 2012, 144:661-668.
38. Guo J.G., Mazella J., Tseng L. Activation of the human IGFBP-1 gene promoter by progestin and relaxin in primary culture of human endometrial stromal cells. Mol. Cell. Endocrinol. 1994, 104:39-46.
39. Halls M.L., Bathgate R.A., Summers R.J. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol. Pharmacol. 2006, 70:214-226.
40. Halls M.L., van der Westhuizen E.T., Bathgate R.A., Summers R.J. Relaxin family peptide receptors - former orphans reunite with their parent ligands to activate multiple signaling pathways. Br. J. Pharmacol. 2007, 150:677-691.
41. Hanna C.B., Yao S., Patta M.C., Jensen J.T., Wu X. Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques. Reprod. Biol. Endocrinol. 2010, 8:150.
42. Hansell D.J., Bryant-Greenwood G.D., Greenwood F.C. Expression of the human relaxin H1 gene in the decidua, trophoblast, and prostate. J. Clin. Endocrinol. Metab. 1991, 72:899-904.
43. Havelock J.C., Bay K., Ivell R., Bathgate R.A., Rodgers R.J., Carr B.R. A novel hormone known as insulin-like factor 3 (INSL3) is expressed in the human ovary and serum levels are increased in women with polycystic ovary syndrome (PCOS). Fertil. Steril. 2005, 84(Suppl. 1):S3.
44. Hayes E.S., Curnow E.C., Trounson A.O., Danielson L.A., Unemori E.N. Implantation and pregnancy following in vitro fertilization and the effect of recombinant human relaxin administration in Macaca fascicularis. Biol. Reprod. 2004, 71:1591-1597.
45. Heng K., Ivell R., Wagaarachchi P., Anand-Ivell R. Relaxin signalling in primary cultures of human myometrial cells. Mol. Hum. Reprod. 2008, 14:603-611.
46. Hossain M.A., Man B.C., Zhao C., Xu Q., Du X.J., Wade J.D., Samuel C.S. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor. Biochemistry 2011, 50:1368-1375.
47. Hsu S.Y., Nakabayashi K., Nishi S., Kumagai J., Kudo M., Sherwood O.D., Hsueh A.J. Activation of orphan receptors by the hormone relaxin. Science 2002, 295:671-674.
48. Hughes I.A., Acerini C.L. Factors controlling testis descent. Eur. J. Endocrinol. 2008, 159(Suppl. 1):S75-S82.
49. Hwang J.J., Lin S.W., Teng C.H., Ke F.C., Lee M.T. Relaxin modulates the ovulatory process and increases secretion of different gelatinases from granulosa and theca-interstitial cells in rats. Biol. Reprod. 1996, 55:1276-1283.
50. Irving-Rodgers H.F., Bathgate R.A.D., Ivell R., Domagalski R., Rodgers R.J. Dynamic changes in the expression of relaxin-like factor (Insl3), cholesterol side-chain cleavage cytochrome P450 and 3ß-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol. Reprod. 2002, 66:934-943.
51. Ivell R. The biology of the relaxin like factor (RLF). Revs. Reprod. 1997, 2:133-138.
52. Ivell R., Anand-Ivell R. The biology of Insulin-like Factor 3 (INSL3) in human reproduction. Hum. Reprod. Update 2009, 15:463-476.
53. Ivell R., Grutzner F. Evolution and male fertility - lessons from INSL6. Endocrinology 2009, 150:3986-3990.
54. Ivell R., Heng K., Anand-Ivell R. Diverse signalling mechanisms used by relaxin in natural cells and tissues - the evolution of a "neohormone". Adv. Exp. Biol. Med. 2007, 612:26-33.
55. Ivell R., Kotula-Balak M., Glynn D., Heng K., Anand-Ivell R. Relaxin family peptides in the male reproductive system - a critical appraisal. Mol. Hum. Reprod. 2011, 17:71-84.
56. Ivell R., Wade J.D., Anand-Ivell R. Insulin-like factor 3 (INSL3) as a biomarker of Leydig cell functional capacity. Biol. Reprod. 2013, 88:1-8.
57. Jauniaux E., Johnson M.R., Jurkovic D., Ramsay B., Campbell S., Meuris S. The role of relaxin in the development of the uteroplacental circulation in early pregnancy. Obstet. Gynecol. 1994, 84:338-432.
58. Johnson M.R., Abdalla H., Allman A.C., Wren M.E., Kirkland A., Lightman S.L. Relaxin levels in ovum donation pregnancies. Fertil. Steril. 1991, 56:59-61.
59. Kamat A.A., Feng S., Bogatcheva N.V., Truong A., Bishop C.E., Agoulnik A.I. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 2004, 145:4712-4720.
60. Kawamura K., Kumagai J., Sudo S., Chun S.Y., Pisarska M., Morita H., Toppari J., Fu P., Wade J.D., Bathgate R.A.D., Hsueh A.J.W. Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc. Natl. Acad. Sci. USA 2004, 101:7323-7328.
61. Kim H.S., Jeong Y.I., Lee J.Y., Jeong Y.W., Hossein M.S., Hyun H.S., Hwang W.S. Effects of recombinant relaxin on in vitro maturation of porcine oocytes. J. Vet. Med. Sci. 2010, 72:333-337.
62. Klonisch T., Bialek J., Radestock Y., Hoang-Vu C., Hombach-Klonisch S. Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness. Adv. Exp. Med. Biol. 2007, 612:104-118.
63. Laurent A., Rouillac C., Delezoide A.L., Giovangrandi Y., Vekemans M., Bellet D., Abitbol M., Vidaud Insulin-like 4 (INSL4) gene expression in human embryonic and trophoblast tissues. Mol. Reprod. Dev. 1998, 51:123-129.
64. Lok S., Johnston D.S., Conklin D., Lofton-Day C.E., Adams R.L., Jeimberg A.C., Whitmore T.E., Schrader S., Griswold M.D., Jaspers S.R. Identification of INSL6, a new member of the insulin family that is expressed in the testis of the human and rat. Biol. Reprod. 2000, 62:1593-1599.
65. Luu V., Hanatate K., Tanihara F., Sato Y., Do L.T.K., Taniguchi M., Otoi T. The effect of relaxin supplementation of in vitro maturation medium on the development of cat oocytes obtained from ovaries stored at 4°C. Reprod Biol 2013, 13:122-126.
66. MacLennan A.H., Grant P., Ness D., Down A. Effect of porcine relaxin and progesterone on rat, pig and human myometrial activity in vitro. J. Reprod. Med. 1986, 31:43-49.
67. Maseelall P.B., Seungdamrong A., Weiss G., Wojtczuk A.S., Donnelly R.L., Stouffer R.L., Goldsmith L.T. Expression of LGR7 in the primate corpus luteum implicates the corpus luteum as a relaxin target organ. Ann. N. Y. Acad. Sci. 2009, 1160:147-151.
68. McGowan B.M., Stanley S.A., Donovan J., Thompson E.L., Patterson M., Semjonous N.M., Gardiner J.V., Murphy K.G., Ghatei M.A., Bloom S.R. Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E278-E286.
69. McGuane J.T., Debrah J.E., Sautina L., Jarajapu Y.P.R., Novak J., Rubin J.P., Grant M.B., Segal M., Conrad K.P. Endocrinology 2011, 152:2786-2796.
70. McMillen I.C., Robinson J.S. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol. Rev. 2005, 85:571-633.
71. Millar L., Streiner N., Webster L., Yamamoto S., Okabe R., Kawamata T., Shimoda J., Büllesbach E., Schwabe C., Bryant-Greenwood G. Early placental insulin-like protein (INSL4 or EPIL) in placental and fetal membrane growth. Biol. Reprod. 2005, 73:695-702.
72. Minagawa I., Fukuda M., Ishige H., Kohriki H., Shibata M., Park E.Y., Kawarasaki T., Kohsaka T. Relaxin-like factor (RLF)/insulin-like peptide 3 (INSL3) is secreted from testicular Leydig cells as a monomeric protein comprising three domains B-C-A with full biological activity in boars. Biochem. J. 2012, 441:265-273.
73. Mita M., Yoshikuni M., Ohno K., Shibata Y., Paul-Prasanth B., Pitchayawasin S., Isobe M., Nagahama Y. A relaxin-like peptide purified from radial nerves induces oocyte maturation and ovulation in the starfish, Asterina pectinifera. Proc. Natl. Acad. Sci. USA 2009, 106:9507-9512.
74. Monk J.M., Leonard S., McBey B.A., Croy B.A. Induction of murine spiral artery modification by recombinant human interferon-gamma. Placenta 2005, 26:835-838.
75. Nef S., Parada L.F. Cryptorchidism in mice mutant for Insl3. Nat. Genet. 1999, 22:295-299.
76. Nguyen B.T., Dessauer C.W. Relaxin stimulates protein kinase C zeta translocation: requirement for cyclic adenosine 3'5'-monophosphate production. Mol. Endocrinol. 2005, 19:1012-1023.
77. Ohleth K.M., Bagnell C.A. Relaxin secretion and gene expression in porcine granulosa and theca cells are stimulated during in vitro luteinization. Biol. Reprod. 1999, 60:499-507.
78. Parry L.J., Vodstrcil L.A. Relaxin physiology in the female reproductive tract during pregnancy. Adv. Exp. Med. Biol. 2007, 612:34-48.
79. Piccinni M.P. T cells in normal pregnancy and recurrent pregnancy loss. Reprod. Biomed. Online 2006, 13:840-844.
80. Piccinni M.P., Bani D., Beloni L., Manuelli C., Mavilia C., Vocioni F., Bigazzi M., Sacchi T.B., Romagnani S., Maggi E. Relaxin favors the development of activated human T cells into Th1-like effectors. Eur. J. Immunol. 1999, 29:2241-2247.
81. Pusch W., Balvers M., Ivell R. Molecular cloning and expression of the relaxin like factor from the mouse testis. Endocrinology 1996, 137:3009-3013.
82. Ramathal C.Y., Bagchi I.C., Taylor R.N., Bagchi M.K. Endometrial decidualization: of mice and men. Semin. Reprod. Med. 2010, 28:17-26.
83. Rogers P.A.W., Murphy C.R., Squires K.R., MacLennan A.H. Effects of relaxin on the intrauterine distribution and antimesometrial positioning and orientation of rat blastocysts before implantation. J. Reprod. Fert. 1983, 68:431-435.
84. Satchell L., Glister C., Bleach E., Bicknell A.B., Dai Y., Anand-Ivell R., Ivell R., Knight P.G. Ovarian expression of insulin-like peptide 3 (INSL3) and its receptor (RXFP2) during development of bovine antral follicles and corpora lutea and measurement of circulating INSL3 levels during synchronized estrous cycles. Endocrinology 2013, 154:1897-1906.
85. Segal M.S., Sautina L., Li S., Diao Y.P., Agoulnik A.I., Kielczewski J., McGuane J.T., Grant M.B., Conrad K.P. Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice. Blood 2012, 119:629-636.
86. Sherwood O.D. Relaxin. The Physiology of Reproduction 1994, 861-1009. Raven Press. second ed. E. Knobil, J.D. Neill (Eds.).
87. Shirota K., Tateishi K., Koji T., Hishikawa Y., Hachisuga T., Kuroki M., Kawarabayashi T. Early human preantral follicles have relaxin and relaxin receptor (LGR7), and relaxin promotes their development. J. Clin. Endocrinol. Metab. 2005, 90:516-521.
88. Shirota K., Tateishi K., Emoto M., Hachisuga T., Kuroki M., Kawarabayashi T. Relaxin-induced angiogenesis in ovary contributes to follicle development. Ann. N. Y. Acad. Sci. 2005, 1041:144-146.
89. Silvertown J.D., Neschadim A., Liu H.N., Shannon P., Walia J.S., Kao J.C., Robertson J., Summerlee A.J., Medin J.A. Relaxin-3 and receptors in the human and rhesus Brain and reproductive tissues. Regul. Pept. 2010, 159:44-53.
90. Siqin, Minagawa I., Okuno M., Yamada K., Sugawara Y., Nagura Y., Hamano K.I., Park E.Y., Sasada H., Kohsaka T. The active form of goat insulin-like peptide 3 (INSL3) is a single-chain structure comprising three domains B-C-A, constitutively expressed and secreted by testicular Leydig cells. Biol. Chem. 2013, (Epub ahead of print).
91. Smith C.M., Shen P.J., Ma S., Sutton S.W., Gundlach A.L. Verification of a relaxin-3 knockout/LacZ reporter mouse as a model of relaxin-3 deficiency. Ann. N. Y. Acad. Sci. 2009, 1160:259-260.
92. Spanel-Borowski K., Schäfer I., Zimmermann S., Engel W., Adham I.M. Increase in final stages of follicular atresia and premature decay of corpora lutea in INSL3-deficient mice. Mol. Reprod. Dev. 2001, 58:281-286.
93. Stewart D.R., Vandevoort C.A. Simulation of human luteal endocrine function with granulosa lutein cell culture. J. Clin. Endocrinol. Metab. 1997, 82:3078-3083.
94. Stewart D.R., Vandevoort C.A. Relaxin secretion by human granulosa cell culture is predictive of in vitro fertilization - embryo transfer success. Hum. Reprod. 1999, 14:338-344.
95. Tang X.M., Chegini N. Human fallopian tube as an extraovarian source of relaxin: messenger ribonucleic acid expression and cellular localization of immunoreactive protein and 125I-relaxin binding sites. Biol. Reprod. 1995, 52:1343-1349.
96. Unemori E.N., Erikson M.E., Rocco S.E., Sutherland K.M., Parsell D.A., Mak K., Grove B.H. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum. Reprod. 1999, 14:800-806.
97. Unemori E.N., Lewis M., Constant J., Arnold G., Grove B.H., Normand J., Deshpande U., Salles A., Pickford L.B., Erikson M.E., Hunt T.K., Huang X. Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites. Wound Repair Regen. 2000, 8:361-370.
98. Van Hiel M.B., Vendersmissen H.P., Van Loy T., Vanden Broeck J. An evolutionary comparison of leucine-rich repeat containing G protein-coupled receptors reveals a novel LGR subtype. Peptides 2012, 34:193-200.
99. Vandevoort C.A., Mtango N.R., Latham K.E., Stewart D.R. Primate preimplantation embryo is a target for relaxin during early pregnancy. Fertil. Steril. 2011, 96:203-207.
100. Wathes D.C., Wardle P.G., Rees J.M., Mitchell J.D., McLaughlin E.A., Hull M.G., Porter D.G. Identification of relaxin immunoreactivity in human follicular fluid. Hum. Reprod. 1986, 1:515-517.
101. Wilson B.C., Burnett D., Rappaport R., Parry L.J., Fletcher E.K. Relaxin-3 and RXFP3 expression, and steroidogenic actions in the ovary of teleost fish. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2009, 153:69-74.
102. Zimmermann S., Steding G., Emmen J.M., Brinkmann A.O., Nayernia K., Holstein A.F., Engel W., Adham I.M. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol. Endocrinol. 1999, 13:681-691.